LABU Direxion Daily S&P Biotech Bull 3x Shares ETF
- 94.110
- +6.600+7.54%
The Most Jam-packed Earnings Week for the Quarter Lies Ahead, Led by These Two Market Bellwethers
'Its clear that Apple is navigating one of the more difficult China demand environments we have seen the last 5 years,' analyst says This week, 175 companies in the S&P 500 index repo
MRNA Is Promising A Breakthrough In Fighting Cancer
When it comes to cancer, there's innovation both on the diagnostics and the treatment front thanks to messenger RNA, or mRNA, a genetic material we all got acquainted with during the COVID-19 era as i
Investors Bid Natera (NASDAQ:NTRA) up US$906m Despite Increasing Losses YoY, Taking Five-year CAGR to 36%
Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies can see their share prices grow by huge amounts. Just think about the savvy in
WHO Picks JN.1 Variant for Next Set of COVID Vaccines
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc
Natera(NTRA.US) Officer Sells US$219.36K in Common Stock
$Natera(NTRA.US)$ Officer Brophy Michael Burkes sold 2,393 shares of common stock on Apr 24, 25, 26, 2024 at an average price of $91.6694 for a total value of $219.36K.Source: Announcement What is sta
Natera(NTRA.US) Director Sells US$89,550 in Common Stock
$Natera(NTRA.US)$ Director Sheena Jonathan sold 1,000 shares of common stock on Apr 25, 2024 at an average price of $89.55 for a total value of $89,550.Source: Announcement What is statement of change
Moderna(MRNA.US) Director Sells US$1.62 Million in Common Stock
$Moderna(MRNA.US)$ Director AFEYAN NOUBAR sold 15,000 shares of common stock on Apr 24, 2024 at an average price of $108.3224 for a total value of $1.62 million.Source: Announcement What is statement
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Vertex Pharmaceuticals Inc's (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite
Rendimiento Legendario, Potencia Moderna: Toyota Tacoma 2024 Con I-FORCE MAX
La primera Tacoma con motor híbrido i-FORCE MAX produce hasta 326 HP y 465 lb-pie de torque i-FORCE MAX de serie en las versiones Trailhunter y TRD Pro, y opcional en TRD Sport, TRD Off-Road y Limit
Should You Buy Moderna Before May 12?
Optimistic Outperform Rating on Sarepta Therapeutics Amid Strong Elevidys Demand and Potential Label Expansion
Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock
How Is The Market Feeling About Moderna?
Moderna's (NYSE:MRNA) short percent of float has fallen 3.53% since its last report. The company recently reported that it has 21.44 million shares sold short, which is 7.38% of all regular shares tha
Express News | Moderna To Present Data From Its Respiratory Portfolio, Including Vaccines And Vaccine Candidates, And Cytomegalovirus Research At ESCMID Global Congress
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates a
Overnight news: US FTC plans to ban Wall Street competition agreement ECB governing board says inflation may still be stubborn, Microsoft and Amazon's AI deals face scrutiny
For more global financial information, please go to the 7×24 hour real-time financial news market closing: US stocks rose and fell three times in a row with S&P in the top 20 US stock turnover on April 24: Tesla pushed back affordable models, and the stock price surged 12%, US WTI crude oil closed down 0.66% on Wednesday and fell 0.66% to below $83. On Wednesday, popular Chinese securities rose 2.9%, NIO, 3.5%, New Oriental fell 14%, European stocks fell 0.39%, and the European Stock 50 index fell 0.39% macro, the US stock market closed down 0.39%, and the US Stock Exchange 50 Index fell 0.39% macro, the US Stock Exchange 50 Index fell 0.39% Macro US CFTCFC banned Wall Street competition agreement, but bankers and “gardening leave” is not in it
Form 144 | Moderna(MRNA.US) Director Proposes to Sell 1.62 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 24, $Moderna(MRNA.US)$ Director NOUBAR B AFEYAN intends to sell 15,000 shares of its common stock on Apr 24, with a total market value of approximately $1.62 million. NOU
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 217.86K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 24, $Natera(NTRA.US)$ Officer MICHAEL BURKES BROPHY intends to sell 2,393 shares of its common stock on Apr 24, with a total market value of approximately $217.86K. MICHA